EUCTR2006-006829-13-NL进行中（未招募）不适用
Antiplatelet therapy in combination with Recombinant t-PA Thrombolysis in Ischemic Stroke - ARTIS
etherlands Heart Foundation0 个研究点目标入组 1,000 人开始时间: 2008年2月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •?patients with an acute ischemic stroke receiving rt-PA thrombolysis
- •?age = 18 years
- •?written informed consent is obtained
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •?known APT in the previous 5 days(in case of uncertainty the patient may be included)
- •?known thrombocytopenia (thrombocyte count = 100 * 10E9/l)
- •?known contra-indications to ASA treatment (e.g. previous adverse reaction to ASA)
- •?known anticoagulance usage in the previous 5 days
- •?known legal incompetence of the patient prior to this stroke
研究者
相似试验
尚未招募
3 期
Antiplatelet therapy in combination with Recombinant t-PA Thrombolysis in Ischemic Strokeischemic stroke1000796310014523NL-OMON31665Academisch Medisch Centrum800
已完成
不适用
oborI dual antiplatelet therapy as aPPropriate duratiON (NIPPON)Coronary Artery DiseaseJPRN-UMIN000006698PO Associations for Establishment of Evidence in Interventions4,598
进行中（未招募）
不适用
ACUTE-PRASJPRN-jRCTs031220079Fujimoto Shigeru200
招募中
不适用
OPTIMA-AF trialPatients with non-valvular Atrial Fibrillation and Ischemic Heart DiseaseNon-valvular atrial fibrillationischemic heart diseaseoral anticoagulantantiplatelet therapy.JPRN-jRCTs051190053Sakata Yasushi1,090
招募中
不适用
Dual-AntiPlatelet Therapy strategies FOR elective PCI in a REAL-world settingNL-OMON51842Amsterdam UMC1,462